Terms: = Pancreatic cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546
11 results:
1. Association of pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy.
Micaily I; Blais EM; Carhart R; Lam S; Cohen SJ; Cannaday SJ; Halverson D; Matrisian LM; DeArbeloa P; Thach D; Petricoin E; Pishvaian MJ; Lavu H; Yeo CJ; Mallick AB
JCO Precis Oncol; 2023 Sep; 7():e2200648. PubMed ID: 38085059
[TBL] [Abstract] [Full Text] [Related]
2. Multistate Model of the Natural History of Inflammatory pancreatic Diseases: A Nationwide Population-based Cohort Study.
Cook ME; Bruun NH; Davidsen L; Drewes AM; Olesen SS
Gastroenterology; 2023 Dec; 165(6):1547-1557.e4. PubMed ID: 37659669
[TBL] [Abstract] [Full Text] [Related]
3. Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound.
Kataoka K; Ishikawa T; Ohno E; Mizutani Y; Iida T; Ishikawa E; Furukawa K; Nakamura M; Honda T; Ishigami M; Kawashima H; Hirooka Y; Fujishiro M
Pancreatology; 2021 Oct; 21(7):1364-1370. PubMed ID: 34281790
[TBL] [Abstract] [Full Text] [Related]
4. A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma.
Wang H; Wang X; Xu L; Zhang J; Cao H
Sci Prog; 2021; 104(2):368504211010938. PubMed ID: 33878963
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival.
Dudani S; de Velasco G; Wells JC; Gan CL; Donskov F; Porta C; Fraccon A; Pasini F; Lee JL; Hansen A; Bjarnason GA; Beuselinck B; Pal SK; Yuasa T; Kroeger N; Kanesvaran R; Reaume MN; Canil C; Choueiri TK; Heng DYC
JAMA Netw Open; 2021 Jan; 4(1):e2021869. PubMed ID: 33475752
[TBL] [Abstract] [Full Text] [Related]
6. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract] [Full Text] [Related]
7. Retrospective analysis of survival after resection of pancreatic renal cell carcinoma metastases.
Rückert F; Distler M; Ollmann D; Lietzmann A; Birgin E; Teoule P; Grützmann R; Wilhelm TJ
Int J Surg; 2016 Feb; 26():64-8. PubMed ID: 26739596
[TBL] [Abstract] [Full Text] [Related]
8. Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.
Kang TW; Kim SH; Lee J; Kim AY; Jang KM; Choi D; Kim MJ
Eur J Radiol; 2015 Nov; 84(11):2089-96. PubMed ID: 26318820
[TBL] [Abstract] [Full Text] [Related]
9. Contrast enhanced ultrasonography prediction of cystic renal mass in comparison to histopathology.
Xu Y; Zhang S; Wei X; Pan Y; Hao J
Clin Hemorheol Microcirc; 2014; 58(3):429-38. PubMed ID: 24165574
[TBL] [Abstract] [Full Text] [Related]
10. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas.
Furukawa T; Kuboki Y; Tanji E; Yoshida S; Hatori T; Yamamoto M; Shibata N; Shimizu K; Kamatani N; Shiratori K
Sci Rep; 2011; 1():161. PubMed ID: 22355676
[TBL] [Abstract] [Full Text] [Related]
11. [Heredity in renal and prostatic neoplasia].
Prayer Galetti T; D'Arrigo L; De Zorzi L; Patarnello T
Arch Ital Urol Androl; 1997 Sep; 69(4):241-6. PubMed ID: 9417296
[TBL] [Abstract] [Full Text] [Related]
